Citation:Burn J, Gerdes AM, Macrae F, Mecklin JP, Moeslein G, Olschwang S, et al 2011

From Cancer Guidelines Wiki

Citation


Burn J, Gerdes AM, Macrae F, Mecklin JP, Moeslein G, Olschwang S, et al. Long-term effect of aspirin on cancer risk in carriers of hereditary colorectal cancer: an analysis from the CAPP2 randomised controlled trial. Lancet 2011 Dec 17;378(9809):2081-7 Available from: http://www.ncbi.nlm.nih.gov/pubmed/22036019.


This is a publication of CAPP2

Critical appraisals

Critical appraisal linkClinical questionAssigned toStatus
Chemopreventive candidate agentsPriyashiel Parikhpending
Chemopreventive candidate agentsDr Albert Chetcuti BTech(Biotech) Hons, PhDcompleted

Compare quality appraisals for each clinical question

  • [[Clinical question:Aspirin for prevention of colorectal cancer|
    Invalid title «<span class="smw-format list-format "><span class="smw-row"><span class="smw-field"><span class="smw-value">Clinical question:Aspirin for prevention of colorectal cancer</span></span></span>»
    ]] (compare critical appraisals)
  • [[Clinical question:Aspirin for prevention of colorectal cancer|
    Invalid title «<span class="smw-row"><span class="smw-field"><span class="smw-value">Clinical question:Aspirin for prevention of colorectal cancer</span></span></span></span>»
    ]] (compare critical appraisals)

Cited by

  1. CAPP2
  2. Chemopreventive candidate agents